James B. Knaak

James B. Knaak

Auto-generated profile, based on publicly available information

James B. Knaak

Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York 14214, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2011 in Toxicology
Verified
Journal Article
Closed access
RFRobert J. Foxenberg
Robert J. Foxenberg
CECorie A. Ellison
Corie A. Ellison
JKJames B. Knaak
James B. Knaak
Chang-Xing MaChang-Xing Ma
Chang-Xing Ma
JOJames R. Olson
James R. Olson

1 January 2004 in Critical Reviews in Toxicology
Verified
Journal Article
Closed access
JKJames B. Knaak
James B. Knaak
CDCurt C. Dary
Curt C. Dary
FPFred Power
Fred Power
CTCarol B. Thompson
Carol B. Thompson
JBJerry N. Blancato
Jerry N. Blancato
A search of the scientific literature was carried out for physiochemical and biological data [i.e., IC50, LD50, Kp (cm/h) for percutaneous absorption, skin/water and tissue/blood partition coefficients, inhibition ki values, and metabolic parameters such as Vmax and Km] on 31 organophosphorus pesticides (OPs) to support the development of predictive quantitative structure–activity relationship (QSAR) and physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) models for human risk assessment. Except for work on parathion, chlorpyrifos, and isofenphos, very few modeling data were found on the 31 OPs of interest. The available percutaneous absorption, partition coefficients and metabolic parameters were insufficient in number to develop predictive QSAR models. Metabolic kinetic parameters (Vmax, Km) varied according to enzyme source and the manner in which the enzymes were characterized. The metabolic activity of microsomes should be based on the kinetic activity of purified or cDNA-expressed cytochrome P450s (CYPs) and the specific content of each active CYP in tissue microsomes. Similar requirements are needed to assess the activity of tissue A- and B-esterases metabolizing OPs. A limited amount of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and carboxylesterase (CaE) inhibition and recovery data were found in the literature on the 31 OPs. A program is needed to require the development of physicochemical and biological data to support risk assessment methodologies involving QSAR and PBPK/PD models.

19 April 2012
Verified
Book Chapter
Closed access
PDF file
JKJames B. Knaak
James B. Knaak
CDCurtis C. Dary
Curtis C. Dary
XZXiaofei Zhang
Xiaofei Zhang
RGRobert W. Gerlach
Robert W. Gerlach
RTR. Tornero-Velez
R. Tornero-Velez
JBJerry N. Blancato
Jerry N. Blancato

1 December 2012 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
CECorie A. Ellison
Corie A. Ellison
ACAlice L. Crane
Alice L. Crane
MBMatthew R. Bonner
Matthew R. Bonner
JKJames B. Knaak
James B. Knaak
RBRichard W. Browne
Richard W. Browne
JOJames R. Olson
James R. Olson